- Home
- ALT vs ORC Comparison
ALT vs ORC Comparison
Compare ALT & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- ORC
- Stock Information
- Founded
- ALT 1997
- ORC 2010
- Country
- ALT United States
- ORC United States
- Employees
- ALT N/A
- ORC N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- ALT Health Care
- ORC Real Estate
- Exchange
- ALT Nasdaq
- ORC Nasdaq
- Market Cap
- ALT 529.9M
- ORC 623.6M
- IPO Year
- ALT N/A
- ORC 2013
- Fundamental
- Price
- ALT $6.83
- ORC $8.03
- Analyst Decision
- ALT Strong Buy
- ORC Buy
- Analyst Count
- ALT 8
- ORC 2
- Target Price
- ALT $19.71
- ORC $9.50
- AVG Volume (30 Days)
- ALT 2.5M
- ORC 2.6M
- Earning Date
- ALT 11-12-2024
- ORC 01-30-2025
- Dividend Yield
- ALT N/A
- ORC 17.93%
- EPS Growth
- ALT N/A
- ORC N/A
- EPS
- ALT N/A
- ORC 1.01
- Revenue
- ALT $52,000.00
- ORC $75,695,000.00
- Revenue This Year
- ALT N/A
- ORC N/A
- Revenue Next Year
- ALT N/A
- ORC N/A
- P/E Ratio
- ALT N/A
- ORC $7.93
- Revenue Growth
- ALT N/A
- ORC N/A
- 52 Week Low
- ALT $5.28
- ORC $7.41
- 52 Week High
- ALT $14.84
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- ALT 41.57
- ORC 59.14
- Support Level
- ALT $6.19
- ORC $7.47
- Resistance Level
- ALT $7.83
- ORC $8.03
- Average True Range (ATR)
- ALT 0.39
- ORC 0.14
- MACD
- ALT -0.04
- ORC 0.02
- Stochastic Oscillator
- ALT 39.02
- ORC 88.89
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.